The IGF axis in prostate cancer.

Monti, S; Proietti-Pannunzi, L; Sciarra, A; Lolli, F; Falasca, P; Poggi, M; Celi, F S; Toscano, V

Monti, S; Proietti-Pannunzi, L; Sciarra, A; Lolli, F; Falasca, P; Poggi, M; Celi, F S; Toscano, V.

Affiliation

Monti S; Azienda Ospedaliera Sant'Andrea, UOC di Endocrinologia, Rome, Italy. salvatore.monti@uniroma1.it

Curr Pharm Des ; 13(7): 719-27, 2007.

Article in En | MEDLINE | ID: mdl-17346186

Subject(s)

Prostatic Neoplasms; Somatomedins/metabolism; Animals; Cell Line, Tumor; Humans; Male; Predictive Value of Tests; Prostatic Neoplasms/epidemiology; Prostatic Neoplasms/etiology; Prostatic Neoplasms/metabolism; Risk; Somatomedins/analysis; Somatomedins/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Somatomedins Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Language: En Journal: Curr Pharm Des Journal subject: FARMACIA Year: 2007 Document type: Article Affiliation country: Italy Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links